In terms of clinical characteristics, GBA1 variant carriers had an average of 4 years earlier in age at onset than non-carriers in our study, consistent with previous studies that found PD patients with GBA1 variants were younger and had 1–11 years earlier in age at onset than PD patients without GBA1 variants23–25. This evidence concerns the gene GBA1 and Parkinson disease.